Geldanamycin interferes with the action of heat shock protein 90 (Hsp90) by binding to the N-terminal ATP binding site and inhibiting an essential ATPase activity. In a program directed toward finding potent, water soluble inhibitors of Hsp90, we prepared a library of over sixty 17-alkylamino-17-demethoxygeldanamycin analogs, and compared their affinity for Hsp90, ability to inhibit growth of SKBr3 mammalian cells, and in selected cases, water solubility. Over 20 analogs showed cell growth inhibition potencies similar to that of 17-allylamino-17-demethoxygeldanamycin (17-AAG), the front-runner geldanamycin analog that is currently in multiple clinical trials. Many of these analogs showed water solubility properties that were desirable for formulation. One of the most potent and water-soluble analogs in the series was 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin (17-DMAG), which was independently prepared by the NCI and will soon enter clinical trials. Importantly, the binding affinity of these analogs to the molecular target Hsp90 does not correlate well with their cytotoxicity in SKBr3 cells.

Synthesis and biological activities of novel 17-aminogeldanamycin derivatives / Z. Q., Tian; Y., Liu; D., Zhang; Z., Wang; S. D., Dong; C. W., Carreras; Y., Zhou; Rastelli, Giulio; D. V., Santi; D. C., Myles. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - ELETTRONICO. - 12:(2004), pp. 5317-5329. [10.1016/j.bmc.2004.07.053]

Synthesis and biological activities of novel 17-aminogeldanamycin derivatives

RASTELLI, Giulio;
2004

Abstract

Geldanamycin interferes with the action of heat shock protein 90 (Hsp90) by binding to the N-terminal ATP binding site and inhibiting an essential ATPase activity. In a program directed toward finding potent, water soluble inhibitors of Hsp90, we prepared a library of over sixty 17-alkylamino-17-demethoxygeldanamycin analogs, and compared their affinity for Hsp90, ability to inhibit growth of SKBr3 mammalian cells, and in selected cases, water solubility. Over 20 analogs showed cell growth inhibition potencies similar to that of 17-allylamino-17-demethoxygeldanamycin (17-AAG), the front-runner geldanamycin analog that is currently in multiple clinical trials. Many of these analogs showed water solubility properties that were desirable for formulation. One of the most potent and water-soluble analogs in the series was 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin (17-DMAG), which was independently prepared by the NCI and will soon enter clinical trials. Importantly, the binding affinity of these analogs to the molecular target Hsp90 does not correlate well with their cytotoxicity in SKBr3 cells.
12
5317
5329
Synthesis and biological activities of novel 17-aminogeldanamycin derivatives / Z. Q., Tian; Y., Liu; D., Zhang; Z., Wang; S. D., Dong; C. W., Carreras; Y., Zhou; Rastelli, Giulio; D. V., Santi; D. C., Myles. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - ELETTRONICO. - 12:(2004), pp. 5317-5329. [10.1016/j.bmc.2004.07.053]
Z. Q., Tian; Y., Liu; D., Zhang; Z., Wang; S. D., Dong; C. W., Carreras; Y., Zhou; Rastelli, Giulio; D. V., Santi; D. C., Myles
File in questo prodotto:
File Dimensione Formato  
17-derHsp90-RastelliBMCL2004.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 368.32 kB
Formato Adobe PDF
368.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/305970
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 149
  • ???jsp.display-item.citation.isi??? 142
social impact